Athersys Inc (ATHXQ)
0.006
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Athersys Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.049M |
| March 31, 2023 | |
| December 31, 2022 | 0.031M |
| September 30, 2022 | 0.065M |
| June 30, 2022 | 2.316M |
| March 31, 2022 | 2.912M |
| December 31, 2021 | 0.722M |
| September 30, 2021 | 4.792M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 1.27M |
| September 30, 2020 | 0.085M |
| June 30, 2020 | 0.077M |
| March 31, 2020 | |
| December 31, 2019 | 0.251M |
| September 30, 2019 | -0.368M |
| June 30, 2019 | 4.193M |
| March 31, 2019 | 1.441M |
| December 31, 2018 | 1.424M |
| September 30, 2018 | 2.218M |
| June 30, 2018 | 19.35M |
| March 31, 2018 | 0.749M |
| December 31, 2017 | 0.955M |
| September 30, 2017 | 0.179M |
| June 30, 2017 | 0.449M |
| Date | Value |
|---|---|
| March 31, 2017 | 1.26M |
| December 31, 2016 | 0.828M |
| September 30, 2016 | 0.15M |
| June 30, 2016 | 0.136M |
| March 31, 2016 | 15.12M |
| December 31, 2015 | 10.10M |
| September 30, 2015 | 0.039M |
| June 30, 2015 | 0.049M |
| March 31, 2015 | 0.106M |
| December 31, 2014 | 0.131M |
| September 30, 2014 | 0.075M |
| June 30, 2014 | 0.036M |
| March 31, 2014 | 0.044M |
| December 31, 2013 | 0.39M |
| September 30, 2013 | 0.087M |
| June 30, 2013 | 0.194M |
| March 31, 2013 | 0.084M |
| December 31, 2012 | 2.024M |
| September 30, 2012 | 0.623M |
| June 30, 2012 | 2.27M |
| March 31, 2012 | 2.463M |
| December 31, 2011 | 1.236M |
| September 30, 2011 | 2.354M |
| June 30, 2011 | 2.435M |
| March 31, 2011 | 2.99M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.368M
Minimum
Sep 2019
4.792M
Maximum
Sep 2021
1.261M
Average
0.251M
Median
Dec 2019
Revenue (Quarterly) Benchmarks
| Merck & Co Inc | 15.78B |
| MEI Pharma Inc | -- |
| ContraFect Corp | -- |
| Bristol-Myers Squibb Co | 11.86B |
| NovaBay Pharmaceuticals Inc | 2.631M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.771M |
| Total Expenses (Quarterly) | 7.78M |
| EPS Diluted (Quarterly) | -0.15 |
| Enterprise Value | 10.14M |
| Earnings Yield | -33.83K% |
| Normalized Earnings Yield | -50500.00 |